Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation

Front Immunol. 2023 Feb 10:14:1114368. doi: 10.3389/fimmu.2023.1114368. eCollection 2023.

Abstract

The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell transplantation (alloHSCT) depends on the fate of individual donor T-cells. To this end, we tracked αβT-cell clonotypes during stem cell mobilization treatment with granulocyte-colony stimulating factor (G-CSF) in healthy donors and for six months during immune reconstitution after transfer to transplant recipients. More than 250 αβT-cell clonotypes were tracked from donor to recipient. These clonotypes consisted almost exclusively of CD8+ effector memory T cells (CD8TEM), which exhibited a different transcriptional signature with enhanced effector and cytotoxic functions compared to other CD8TEM. Importantly, these distinct and persisting clonotypes could already be delineated in the donor. We confirmed these phenotypes on the protein level and their potential for selection from the graft. Thus, we identified a transcriptional signature associated with persistence and expansion of donor T-cell clonotypes after alloHSCT that may be exploited for personalized graft manipulation strategies in future studies.

Keywords: T-cells; allogeneic HSCT; clonal tracking; leukemia; scRNAseq; transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Tracking
  • Drug-Related Side Effects and Adverse Reactions*
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Stem Cell Transplantation

Grants and funding

The work was supported by grants from BIH and research funding from the Stiftung Charité (BIH Johanna Quandt funding).